The BTX / Botulinum Toxin Treatment Notes Template (Dental Context)

A BTX / botulinum toxin treatment notes template captures the legally-compliant BTX administration — indication (therapeutic for bruxism/TMD or cosmetic), face-to-face assessment (remote prescribing prohibited per JCCP), full MHx with neuromuscular contraindications, pre-treatment photographs, written consent including cooling-off period, product with batch number, injection sites and units mapped on diagram or photo, post-procedure instructions, and 2-week review — meeting GDC Scope of Practice, JCCP guidance, and Medicines Act 1968 (POM).

Remote-only BTX consultation is explicitly prohibited and voids indemnity cover with most providers. Below is the template UK dentists paste into their PMS for any compliant BTX administration.

Download the free BTX / Botulinum Toxin Treatment template — plain text, GDC/FGDP(UK)-aligned.

Why this btx / botulinum toxin treatment template wins

  • Face-to-face assessment EXPLICIT — JCCP-mandated, voids "remote prescribing" indemnity issue.
  • Indemnity confirmation documented — BTX is high-risk for indemnity disputes if not specifically covered.
  • Pre-treatment photographs — DDU + JCCP best practice.
  • Batch / lot number — Medicines Act 1968 traceability.
  • Injection sites + units mapped — defends against asymmetry or over-dose claims.
  • Cooling-off period documented — JCCP best practice for cosmetic procedures.

Compliance: the medico-legal angle

  • GDC Scope of Practice — BTX not listed as dentistry but dentists may prescribe as registered prescribers (with training).
  • Medicines Act 1968 — BTX is POM (prescription-only medicine), traceability mandatory.
  • JCCP (Joint Council for Cosmetic Practitioners) — guidance for cosmetic procedures including BTX.
  • Montgomery — extensive consent for elective cosmetic / therapeutic procedure.
  • Indemnity — most providers (DDU, Dental Protection, MDDUS) require specific cosmetic add-on cover for BTX above £8,000 annual cosmetic income.

Common mistakes UK dentists make

  • Remote-only / online consultation — voids indemnity, JCCP non-compliance.
  • No batch / lot number — Medicines Act breach, no traceability for adverse events.
  • Injection sites and doses not mapped — undefendable if asymmetry or over-treatment claim.
  • No cooling-off period for cosmetic — JCCP best practice ignored.
  • No pre-treatment photographs — outcomes disputes have no baseline.

Frequently asked questions

Can dentists provide BTX?

Yes — UK dentists are registered prescribers and may prescribe BTX with appropriate training, competence, and indemnity. GDC Scope of Practice does not list BTX as dentistry per se but does not prohibit dentist prescribing for therapeutic (bruxism, TMD) or cosmetic indications within competence. Confirm indemnity cover.

Why is remote consultation prohibited?

JCCP / RCS / GMC guidance: BTX is POM. Face-to-face clinical assessment is required to confirm indication, exclude contraindications, assess suitable anatomy, and obtain informed consent. Remote-only "telehealth" BTX consultations contravene this and most indemnity providers explicitly void cover for remote BTX work.

What's the cooling-off period?

JCCP best practice for cosmetic procedures: minimum 14 days between consultation and first treatment to allow informed reflection. Repeat treatments don't require renewed cooling-off. Documenting it is the defence against impulse-treatment regret claims.

Therapeutic vs cosmetic BTX — different rules?

Same legal framework (POM, face-to-face, consent). Different indemnity — therapeutic (bruxism, TMD) often covered by standard dental indemnity. Cosmetic (glabellar, crow's feet, gummy smile) often requires additional cosmetic indemnity add-on if income exceeds providers' threshold (typically £8,000/year cosmetic).

How long does BTX last?

3-4 months for both therapeutic and cosmetic. Patient must accept the need for repeat treatments for sustained effect. Discuss at consent.

What if I cause ptosis?

Eyelid droop from spread to levator palpebrae. Usually resolves within 4-6 weeks as BTX wears off. Apraclonidine eyedrops can provide partial relief in interim. Manage with patient honesty, document, and refer to specialist if severe. Avoid by careful injection depth and avoiding the inferior orbital region.

Related dental note templates